/Companies

Xenagos Bio

Philadelphia, US · Founded 2025 · Delaware corporation

Find your way into Xenagos Bio

Sign up to see every warm intro you have to Xenagos Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xenagos Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

MJ
Michael J. McElhaughPresident, Chief Executive Officer and FounderChief Business Officer at Arbutus Biopharma Corporation

Board

AD
Abel De La RosaBoard director
PH
Patrick HigginsBoard director

Reported raises · per SEC filings

Form D private placements

$2.5M disclosed across 1 round · 2026

▶$2.5MraisedMay 2026 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Abel De La RosaDirector
  • Michael J. McElhaughExecutive Officer, Director
  • Patrick HigginsDirector
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Xenagos Bio raised?
Xenagos Bio has disclosed $2.5M raised across 1 round.
Where is Xenagos Bio headquartered?
Xenagos Bio is headquartered in Philadelphia, US.